Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 3 results for "Tecfidera"

Biogen wins ruling in Tecfidera IP case; shares rise
Reuters

Biogen wins ruling in Tecfidera IP case; shares rise

NEW YORK (Reuters) - Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down. Reuters, 5 days ago

23 images for Tecfidera

Reuters, 5 days ago
pharmaphorum, 2 months ago
Nasdaq, 1 month ago
Ariva.de, 1 month ago
Nasdaq, 1 month ago
Medical Marketing And Media, 2 months ago
Yahoo! Finance, 2 months ago
Scrip Intelligence, 2 months ago
FiercePharma, 2 months ago
Zacks.com, 2 months ago
Reuters

Biogen to pay Forward Pharma $1.25 billion to protect MS drug

(Reuters) - Biogen Inc said on Tuesday it would pay Forward Pharma A/S $1.25 billion to license the Danish company's patents covering multiple sclerosis drugs, providing Biogen an insurance policy on future sales of Tecfidera, its blockbuster oral treatment ...
 Reuters2 months ago Biogen in $1.25 bln deal with Forward Pharma to protect MS drug  Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less